Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C9H12O4 |
| Molecular Weight | 184.1892 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(=CC=C1O)C(O)CO
InChI
InChIKey=FBWPWWWZWKPJFL-UHFFFAOYSA-N
InChI=1S/C9H12O4/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,10-12H,5H2,1H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder. | 2006-10 |
|
| Aromatic l-aminoacid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis. | 2006-01 |
|
| Early-onset encephalopathy and cortical myoclonus in a boy with MECP2 gene mutation. | 2004-11-23 |
|
| Effects of catecholamine depletion on D2 receptor binding, mood, and attentiveness in humans: a replication study. | 2003-01 |
|
| Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. | 2002-04-15 |
|
| Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humans. | 2002 |
|
| Association of plasma free-3-methoxy-4-hydroxyphenyl (ethylene)glycol, natural killer cell activity and delirium in postoperative patients. | 2001-11 |
|
| A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. | 2001-08 |
|
| Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. | 2001-03 |
|
| L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. | 1998-11 |
|
| Biochemical hallmarks of tyrosine hydroxylase deficiency. | 1998-09 |
|
| Monoamine neurotransmitter metabolites and spontaneous recurrence of methamphetamine psychosis. | 1997 |
|
| Plasma monoamine metabolites and spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory psychosis: relation of noradrenergic activity to the occurrence of flashbacks. | 1996-07-31 |
|
| Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. | 1996-05-01 |
|
| Decreased lumbar cerebrospinal fluid levels of monoamine metabolites in vascular dementia. | 1996 |
|
| Cerebrospinal fluid levels of monoamine metabolites in panic disorder. | 1991-03 |
|
| Associated norepinephrine loss following calcium-induced spinal paralysis. | 1988-03-01 |
|
| Urinary monoamine metabolites as indices of mental stress in healthy males and females. | 1986-06 |
|
| Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment. | 1986-02 |
|
| Urinary 3-methoxy-4-hydroxyphenylglycol in affective and schizophrenic patients. Behavior and symptom correlates. | 1986 |
|
| Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage. | 1985 |
|
| 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard. | 1984-12-12 |
|
| Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. | 1984-03 |
|
| Reduction of MOPEG levels in cerebrospinal fluid of psychotic women after electroconvulsive treatment. | 1979-08-08 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
1684-0
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
50135-3
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
53496-6
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
43634-5
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
50137-9
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
9695-8
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
50136-1
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
50138-7
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
47538-4
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
21043-5
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
||
|
LOINC |
53098-0
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
10805
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
98LK01183Z
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
DTXSID20862142
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
534-82-7
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | |||
|
m7339
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
3-Methoxy-4-hydroxyphenylglycol
Created by
admin on Mon Mar 31 22:02:34 GMT 2025 , Edited by admin on Mon Mar 31 22:02:34 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD